Selective interventional treatment of the ophthalmic branch
The ophthalmic branch (V1) of the trigeminal nerve
The ophthalmic branch (V1) of the trigeminal nerve innervates the following regions:
- frontal
- orbital
- periocular
- upper part of the nasal bridge
V1 also carries sensation from the cornea, which is vital for eye protection. Pain in this territory therefore requires a precise diagnosis and target evaluation before any procedure.
For this reason, every intervention on V1 requires:
- extremely selective indications
- specific expertise
- accurate planning
When V1 radiofrequency is considered
Trigeminal V1 radiofrequency is not a routine procedure. It may be considered only in selected cases, in the presence of:
- trigeminal neuralgia with clear involvement of the ophthalmic branch
- V1 trigeminal pain refractory to pharmacological therapy
- a diagnosis that is consistent and stable over time
- failure of or intolerance to conservative treatments
Simple periocular pain is not enough to indicate radiofrequency. In neuralgia, carbamazepine and oxcarbazepine are the first-choice drugs; when these are insufficient or poorly tolerated, alternatives are discussed. In the classical form, microvascular decompression is the first recommended surgical option, if appropriate for the patient. EAN Guidelines.
Why selection is fundamental
The V1 territory is functionally critical. An inappropriate indication can lead to:
- unjustified risks
- undesired sensory alterations
- worsening of quality of life
For this reason, not all patients with V1 pain are candidates for radiofrequency.
Clinical pathway before the procedure
Before considering trigeminal V1 radiofrequency, a complete specialist pathway is indispensable, including:
- In-depth clinical evaluation
- Confirmation of the trigeminal neuralgia diagnosis
- Distinction from ocular pathologies, neuropathies, and headaches, including cluster headache
- Review of clinical and therapeutic history
- Review of MRI and other available tests
- Any selective diagnostic tests
A diagnostic block may provide information, but it does not confirm the diagnosis on its own and does not guarantee the outcome of the radiofrequency. Learn more about the diagnostic pathway.
Technique and treatment target
Treatment of a peripheral branch, such as the supraorbital nerve, is different from treatment at the ganglion level. The term “V1 radiofrequency” must therefore be accompanied by an explanation of the target. Modalities include:
- pulsed radiofrequency: pulses aimed at modulating nerve activity while limiting thermal effects; it is not without risks
- thermal or lesional radiofrequency: produces a controlled lesion; in the V1 territory, it requires particular attention to the effects on corneal sensitivity
The two modalities are not equivalent: results and risks must be related to the specific procedure. Consult the general page on trigeminal radiofrequency. The choice depends on:
- type of pain
- duration
- anatomical target and results of any preliminary tests
- individual risk profile
How the procedure is performed
Trigeminal V1 radiofrequency is performed:
- in a controlled environment
- under sterile conditions
- under fluoroscopic guidance
- with parameters selected on a case-by-case basis
Precision of placement is an essential element for safety.
Risks and specific considerations
In the treatment of the ophthalmic branch, it is necessary to carefully consider:
- numbness or abnormal painful sensations in the treated area
- transient post-procedure discomfort or pain
- in treatments involving corneal fibres, reduction of sensitivity and the corneal reflex, with decreased eye protection
Bleeding or infection at the access point are also possible. In lesional procedures, persistent pain in an insensitive area (anaesthesia dolorosa) may rarely occur. The risk varies with technique and target and is not the same for a peripheral cutaneous branch as for a ganglion procedure. RCS Guidelines on Trigeminal Neuralgia.
Expected benefits and limitations
In correctly selected patients, the procedure can lead to:
- significant reduction in pain intensity
- decrease in the frequency of attacks
- improvement in quality of life
Follow-up evaluation assesses pain, sensitivity, and the need for therapy; any reduction in medication must be agreed upon with the treating physician. If a reduction in the corneal reflex is detected, a specific eye protection and monitoring plan is required. It is essential to clarify that:
- the response is not uniform
- the effect may be temporary
- there are no guaranteed results
Clinical experience
Trigeminal V1 radiofrequency is performed by Dr Evangelos Panagiotakos MD as part of a specialist pathway dedicated to complex craniofacial pain, with a rigorous and selective approach developed through the management of complex cases.
